Chicago Partners Investment Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-7,567
| Closed | -$774K | – | 1510 |
|
|
2025
Q4 | $774K | Sell |
7,567
-5,283
| -41% | -$424K | 0.02% | 551 |
|
|
2025
Q3 | $813K | Buy |
12,850
+1,780
| +16% | +$88.9K | 0.02% | 490 |
|
|
2025
Q2 | $536K | Buy |
11,070
+1,429
| +15% | +$72.6K | 0.02% | 571 |
|
|
2025
Q1 | $514K | Sell |
9,641
-571
| -6% | -$28.9K | 0.02% | 512 |
|
|
2024
Q4 | $579K | Buy |
10,212
+951
| +10% | +$59.2K | 0.02% | 463 |
|
|
2024
Q3 | $651K | Buy |
9,261
+158
| +2% | +$8.92K | 0.02% | 423 |
|
|
2024
Q2 | $424K | Hold |
9,103
| – | – | 0.02% | 513 |
|
|
2024
Q1 | $578K | Hold |
9,103
| – | – | 0.02% | 411 |
|
|
2023
Q4 | $585K | Hold |
9,103
| – | – | 0.03% | 393 |
|
|
2023
Q3 | $583K | Hold |
9,103
| – | – | 0.03% | 372 |
|
|
2023
Q2 | $775K | Hold |
9,103
| – | – | 0.04% | 328 |
|
|
2023
Q1 | $603K | Hold |
9,103
| – | – | 0.04% | 345 |
|
|
2022
Q4 | $624K | Sell |
9,103
-30
| -0.3% | -$1.23K | 0.04% | 326 |
|
|
2022
Q3 | $349K | Hold |
9,133
| – | – | 0.02% | 410 |
|
|
2022
Q2 | $412K | Hold |
9,133
| – | – | 0.03% | 370 |
|
|
2022
Q1 | $475K | Sell |
9,133
-40
| -0.4% | -$2.92K | 0.04% | 326 |
|
|
2021
Q4 | $719K | Hold |
9,173
| – | – | 0.05% | 278 |
|
|
2021
Q3 | $826K | Buy |
9,173
+500
| +6% | +$52.8K | 0.06% | 256 |
|
|
2021
Q2 | $984K | Buy |
8,673
+463
| +6% | +$55.3K | 0.07% | 217 |
|
|
2021
Q1 | $1.14M | Sell |
8,210
-447
| -5% | -$61.2K | 0.09% | 181 |
|
|
2020
Q4 | $1.3M | Sell |
8,657
-1,997
| -19% | -$242K | 0.12% | 144 |
|
|
2020
Q3 | $1.34M | Sell |
10,654
-671
| -6% | -$57.9K | 0.16% | 113 |
|
|
2020
Q2 | $1.09M | Buy |
11,325
+607
| +6% | +$48.5K | 0.14% | 122 |
|
|
2020
Q1 | $800K | Buy |
10,718
+38
| +0.4% | +$3.08K | 0.12% | 134 |
|
|
2019
Q4 | $959K | Buy |
10,680
+33
| +0.3% | +$2.9K | 0.12% | 130 |
|
|
2019
Q3 | $947K | Sell |
10,647
-106
| -1% | -$12.1K | 0.13% | 118 |
|
|
2019
Q2 | $1.25M | Hold |
10,753
| – | – | 0.18% | 99 |
|
|
2019
Q1 | $992K | Buy |
+10,753
| New | +$915K | 0.15% | 108 |
|
|
2018
Q4 | – | Sell |
-3,100
| Closed | -$191K | – | 513 |
|
|
2018
Q3 | $191K | Buy |
3,100
+1,000
| +48% | +$65.2K | 0.03% | 313 |
|
|
2018
Q2 | $126K | Buy |
2,100
+100
| +5% | +$5.38K | 0.02% | 345 |
|
|
2018
Q1 | $81K | Hold |
2,000
| – | – | 0.01% | 381 |
|
|
2017
Q4 | $105K | Buy |
2,000
+500
| +33% | +$26.7K | 0.02% | 348 |
|
|
2017
Q3 | $71K | Sell |
1,500
-2,000
| -57% | -$80.5K | 0.01% | 386 |
|
|
2017
Q2 | $80K | Buy |
+3,500
| New | +$108K | 0.02% | 307 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Chicago Partners Investment Group's EXAS Position: Q1 2026 in Review
Chicago Partners Investment Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 7,567 shares — an estimated $774K sold.
Chicago Partners Investment Group first reported a position in EXAS in Q2 2017 and held it in 34 quarters. The position peaked at $1.34M in Q3 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Chicago Partners Investment Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Chicago Partners Investment Group sold 7,567 Exact Sciences shares in Q1 2026, an estimated $774K.
- Chicago Partners Investment Group first reported a position in Exact Sciences in Q2 2017 and held it in 34 quarters.
- Chicago Partners Investment Group's Exact Sciences position peaked at $1.34M in Q3 2020.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Chicago Partners Investment Group's 13F filing for Q1 2026, filed 4 May 2026.